(18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica

C Lavado-Pérez1, I Martínez-Rodríguez1, N Martínez-Amador1

  • 1Department of Nuclear Medicine, Molecular Imaging Group (IDIVAL), Marqués de Valdecilla University Hospital, University of Cantabria, Santander, Spain.

Abstract

Insights

18F-FDG PET/CT effectively identifies large vessel vasculitis (LVV) in polymyalgia rheumatica (PMR) patients. This imaging technique significantly impacted treatment decisions for a high percentage of diagnosed LVV cases.

Area of Science:

  • Nuclear Medicine
  • Rheumatology
  • Vascular Imaging

Background:

  • Polymyalgia rheumatica (PMR) can co-occur with large vessel vasculitis (LVV).
  • LVV associated with PMR often necessitates more aggressive treatment strategies.
  • Accurate diagnosis of concurrent LVV is crucial for appropriate patient management.

Purpose of the Study:

  • To assess the utility of 18F-FDG PET/CT in diagnosing LVV in patients with PMR.
  • To evaluate the impact of 18F-FDG PET/CT findings on therapeutic decisions for associated LVV.

Main Methods:

  • Prospective study of 40 patients with PMR and suspected LVV.
  • 18F-FDG PET/CT scans performed 180 minutes post-injection.
  • Visual analysis of five vascular regions (supra-aortic trunks, thoracic aorta, abdominal aorta, iliac arteries, femoral/tibioperoneal arteries) with uptake grading (0-3).

Main Results:

  • LVV diagnosed in 26/40 patients (65%).
  • Highest 18F-FDG uptake observed in thoracic aorta, supra-aortic trunks, and femoral/tibioperoneal arteries in LVV patients.
  • Treatment modification occurred in 85% (17/20) of treated LVV patients based on PET/CT findings.

Conclusions:

  • 18F-FDG PET/CT is valuable for detecting LVV in PMR patients.
  • Identification of vascular inflammation via PET/CT significantly influenced treatment changes.
  • This imaging modality aids in optimizing management for PMR patients with associated LVV.